Legislative and regulatory issues affecting SMID rare disease biotech companies.
2026 · 1st Quarter (Jan 1 - Mar 31)
AMICUS THERAPEUTICS, INC.
Filed by CAPITOL COUNSEL LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Feb 25, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- CAPITOL COUNSEL LLC
- Filing UUID
- 8f32dd4a-9938-449a-805d-4ea73a8a579a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Legislative and regulatory issues affecting SMID rare disease biotech companies.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.